TCL065

TCL065
Please request pricing for this article.
Request Pricing

Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-TCL-01227-10mg 10 mg - - -

5 - 10 business days*

-
TGM-TCL-01227-50mg 50 mg - - -

5 - 10 business days*

-
 
Description: TCL065, an ionizable cationic lipid (pKa = 6.3), is utilized in the creation of... more
Product information "TCL065"
Description: TCL065, an ionizable cationic lipid (pKa = 6.3), is utilized in the creation of lipid nanoparticles (LNPs) for the delivery of mRNA and single-guide RNA (sgRNA) both in vitro and in vivo. When LNPs with TCL065 encapsulate sgRNA targeting the donor site of dystrophin exon 45, along with those targeting the splicing acceptor site of dystrophin exon 45, dystrophin expression is restored in myoblasts derived from induced-pluripotent stem (iPS) cells from Duchenne muscular dystrophy (DMD) patients. Additionally, TCL065-containing LNPs encapsulating mRNA encoding Cas9 nuclease, combined with those containing sgRNA targeting the Rosa26 locus, have been applied for CRISPR-mediated gene editing in mouse gastrocnemius muscle. Target: Others. Smiles: O=C(OCC(COC(=O)CC(CCCCC)CCCCC)(COC(=O)CC(CCCCC)CCCCC)COC(=O)CC(CCCCC)CCCCC)CCCCN(C)C
Supplier: TargetMol
Supplier-Nr: TCL-01227

Properties

MW: 852.32 D
Formula: C51H97NO8

Database Information

Handling & Safety

Storage: +4°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "TCL065"
Write a review
or to review a product.
Viewed